ECSP972094A - NEW 4 (3H) - QUINAZOLINONES 2,3 DISSTITUTED - Google Patents

NEW 4 (3H) - QUINAZOLINONES 2,3 DISSTITUTED

Info

Publication number
ECSP972094A
ECSP972094A ECSP972094A ECSP972094A EC SP972094 A ECSP972094 A EC SP972094A EC SP972094 A ECSP972094 A EC SP972094A EC SP972094 A ECSP972094 A EC SP972094A
Authority
EC
Ecuador
Prior art keywords
disstituted
quinazolinones
new
quinazolinone
compounds
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Willard Mckowan Welch
Mark L Elliott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972094 priority Critical patent/ECSP972094A/en
Publication of ECSP972094A publication Critical patent/ECSP972094A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos compuestos de 4(3h)- quinazolinona 2,3 disustituídas de la fórmula I, a sus sales farmacéuticamente aceptables, a composiciones farmacéuticas y a procedimientos de tratamiento de afecciones neurodegenerativas y relacionadas con traumatismo del SNC.The present invention relates to novel disubstituted 4 (3h) -quinazolinone 2,3 compounds of formula I, their pharmaceutically acceptable salts, pharmaceutical compositions, and methods of treating CNS trauma-related and neurodegenerative conditions.

ECSP972094 1997-04-25 1997-04-25 NEW 4 (3H) - QUINAZOLINONES 2,3 DISSTITUTED ECSP972094A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972094 ECSP972094A (en) 1997-04-25 1997-04-25 NEW 4 (3H) - QUINAZOLINONES 2,3 DISSTITUTED

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972094 ECSP972094A (en) 1997-04-25 1997-04-25 NEW 4 (3H) - QUINAZOLINONES 2,3 DISSTITUTED

Publications (1)

Publication Number Publication Date
ECSP972094A true ECSP972094A (en) 1998-04-24

Family

ID=42042926

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972094 ECSP972094A (en) 1997-04-25 1997-04-25 NEW 4 (3H) - QUINAZOLINONES 2,3 DISSTITUTED

Country Status (1)

Country Link
EC (1) ECSP972094A (en)

Similar Documents

Publication Publication Date Title
GT199700049A (en) NEW 4 (3H) -QUINAZOLINONES 2,3 DISSTITUTED
MY117896A (en) Quinazoline derivatives
PA8447001A1 (en) ATROPISOMEROS 3- 3- ARIL-4 (3H) - QUINAZOLINONAS
AR038427A2 (en) COMPOUNDS 15-RENT-14-HYDROXYL OF MARCFORTINA AND PARAHERCUAMIDA
DE69032609D1 (en) Metalloproteinase inhibitors
TR200001189T2 (en) Dipeptide nitriles.
DE69927050D1 (en) BIPHENYL COMPOUNDS AND BIPHENYL ANALOGS AS INTERGRIN ANTAGONISTS
NO20024042D0 (en) Aryl-fused azapolycyclic compounds
BR9910025A (en) N- (3-Ethinylphenylamino) -6,7-bis (2-methoxyethoxy) -4-quinazo linamine dehydrated and monohydrated mesylate
DK0989973T3 (en) Chalcones with antiproliferative activity
SE9801494D0 (en) Novel use
ITMI951402A0 (en) PROCEDURE FOR THE SYNTHESIS OF UREA INCLUDING TWO SEPARATE REACTION ZONES
BR9713207A (en) Derivatives of 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepane useful as matrix metalloproteinase inhibitors
AP9801202A0 (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
TR199800543A2 (en) Benzyloxy substituted anilylated N-heterocyclic compounds.
TR199700694T1 (en) Dermatological use of vitamin D derivatives.
MX9300361A (en) DERIVED FROM 4-ARYL-3-HETEROARILUREIDOQUINOLINE AS ANTI-HYPERCHOLESTEROLEMIC AND ANTI-ATHEROSCLEROTIC AGENTS.
ES2161365T3 (en) THROMBIN INHIBITORS.
ATE266029T1 (en) SUBSTITUTED PYRROLOBENZIMIDAZOLE DERIVATIVES FOR ANTI-INFLAMMATORY
ECSP972094A (en) NEW 4 (3H) - QUINAZOLINONES 2,3 DISSTITUTED
CO5570673A2 (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
DK0804186T3 (en) Indolditerpenalkaloid compounds
ATE398614T1 (en) TRIAZOLE COMPOUNDS AND THEIR THERAPEUTIC USE
ECSP982408A (en) ATROPISOMEROS DE 3- HETEROARIL - 4 (3H) - QUINAZOLINONAS
ES530199A0 (en) PROCEDURE FOR THE PREPARATION OF 4-AMINO-6, 7-DIMETOXI-2- (4- (FURO-2-IL) -PIPERAZIN-1-IL) -QUINAZOLINE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS